Download PDF
Z Gastroenterol 2007; 45(11): 1185-1190
DOI: 10.1055/s-2007-963529
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Therapie der HIV-assoziierten Ösophagitis

HIV und ÖsophagitisDiagnosis and Therapy of HIV Associated EsophagitisHIV and EsophagitisH. Neumann1 , K. Mönkemüller1
  • 1Zentrum für Gastroenterologie, Hepatologie und Infektiologie, Otto-von-Guericke-Universität Magdeburg
Further Information

Publication History

Manuskript eingetroffen: 13.7.2007

Manuskript akzeptiert: 15.8.2007

Publication Date:
19 November 2007 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Erkrankungen des gastrointestinalen Traktes zählen gegenwärtig zu den häufigsten, mit dem acquired immunodeficiency syndrome (AIDS) assoziierten Komplikationen. Obwohl die Erfahrungen in der Diagnostik und Therapie dieser opportunistischen Infektionen seit den frühen 90er-Jahren deutlich zugenommen haben und sich auch das therapeutische Spektrum sehr entwickelt hat, so sind wir gegenwärtig noch immer nicht in der Lage, für alle opportunistischen Infektionen eine effektive Diagnostik und Therapie anzubieten. Der folgende Artikel soll einen Überblick über die aktuellen Möglichkeiten in der Differenzialdiagnostik und Therapie von mit dem HI-Virus assoziierten Infektionen des oberen Gastrointestinaltraktes geben.

Abstract

Diseases of the gastrointestinal tract are one of the most common complication of the acquired immunodeficiency syndrome (AIDS). Although there have been advances in the diagnosis and therapy of GI diseases in AIDS, currently, the diagnosis of and therapy for such opportunistic diseases still represent a challenge. The following article focuses on the diagnostic approach, differential diagnosis of and therapy for opportunistic esophageal diseases in AIDS.

Schlüsselwörter

Ösophagitis - HIV - Diagnose - Therapie

Key words

oesophagitis - HIV - Diagnosis - therapy

Literatur

  • 1 Mönkemüller K E, Call S A, Lazenby A J. et al . Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.  Am J Gastroenterol. 2000;  95 457-462
    Google Scholar
  • 2 Mönkemüller K E, Lazenby A J, Lee D H. et al . Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.  Dig Dis Sci. 2005;  50 230-234
    Google Scholar
  • 3 Weinert M, Grimes R M, Lynch D P. Oral manifestations of HIV infection.  Ann Intern Med. 1996;  125 485-496
    Google Scholar
  • 4 Wilcox C M, Straub R F, Clark W S. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulcer.  Am ] Gastroenterol. 1995;  90 1938-1941
    Google Scholar
  • 5 Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection: a prospective study of 110 patients.  Arch Intern Med. 1991;  151 1567-1572
    Google Scholar
  • 6 Wilcox C M. Evaluation of a technique to examine the underlying mucosa in patients with AIDS and severe Candida esophagitis.  Gastrointest Endosc. 1995;  42 360-363
    Google Scholar
  • 7 Coleman D C, Bennett D E, Sullivan D J. et al . Oral Candida in HIV infection and AIDS: new perspectives/new approaches.  Crit Rev Microbiol. 1993;  19 61-82
    Google Scholar
  • 8 Sullivan D J, Henman M C, Moran G P. et al . Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species.  J Med Microbiol. 1996;  44 399-408
    Google Scholar
  • 9 Fichtenbaum C J, Koletar S, Yiannotsos C. et al . Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.  Clin Infect Dis. 1998;  26 556-565
    Google Scholar
  • 10 Gallant J E, Moore R D, Richman D D. et al . Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine.  J Infect Dis. 1992;  166 1223-1227
    Google Scholar
  • 11 Mönkemüller K E, Wilcox C M. Diagnosis and treatment of colonic disease in AIDS.  Gastrointest Endosc Clin N Am. 1998;  8 889-911
    Google Scholar
  • 12 Wilcox C M, Schwartz D A, Clark W S. Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome.  Ann Intern Med. 1995;  123 143-149
    Google Scholar
  • 13 Bagdades E K, Pillay D, Squire S B. et al . Relationship between herpes simplex virus u1ceration and CD 4 + cell counts in patients with HIV infection.  AIDS. 1992;  6 1317-1320
    Google Scholar
  • 14 Mönkemüller K E, Wilcox C M. Diagnosis and treatment of esophageal ulcers in AIDS.  Compr Ther. 2000;  26 163-168
    Google Scholar
  • 15 Kotler D P, Reka S, Orenstein I M. et al . Chronic idiopathic esophageal ulceration in the acquired immunodeficiency syndrome.  Mod Pathol. 1995;  8 568-572
    Google Scholar
  • 16 Wilcox C M, Zaki S R, Coffield L M. et al . Evaluation of idiopathic esophageal ulcer for human immunodeficiency virus.  Mod Pathol. 1995;  8 568-572
    Google Scholar
  • 17 Raufman J P. Odynophagia/dysphagia in AIDS.  Gastroenterol Clin North Am. 1988;  17 599-614
    Google Scholar
  • 18 Genereau T, Lortholary O, Bouchaud O. et al . Herpes simplex esophagitis in patients with AIDS: report of 34 cases.  Clin Infect Dis. 1996;  22 926-931
    Google Scholar
  • 19 Wilcox C M, Straub R A, Schwartz D A. Prospective endoscopic characterization of cytomegalovirus esophagitis in patients with AIDS.  Gastrointest Endosc. 1994;  40 481-484
    Google Scholar
  • 20 Mönkemüller K E, Bussian A H, Lazenby A J. et al . Special histologic stains are rarely beneficial for the evaluation of HIV-related gastrointestinal infections.  Am J Clin Pathol. 2000;  114 387-389
    Google Scholar
  • 21 Wilcox C M, Alexander L N, Clark W S. et al . Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms.  Gastroenterology. 1996;  110 1803-1809
    Google Scholar
  • 22 Koletar S L, Russell J A, Fass R J. et al . Comparison of oral f1uconazole and c1otrimazole troches as treatment of oral candidiasis in patients infected with human immunodeficiency virus.  Antimicrob Agents Chemother. 1990;  34 2267-2268
    Google Scholar
  • 23 Pons V, Greenspan D, Derbruin M. et al . Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches.  J Acquir Immune Defic Syndr. 1993;  6 1311-1316
    Google Scholar
  • 24 Pons V, Greenspan D, Lozada-Nur F. et al . Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.  Clin Infect Dis. 1997;  24 1204-1207
    Google Scholar
  • 25 DeWit S, Goosens H, Clumeck N. Single-dose versus 7 days of fluconazole treatment for oral candidiasis in human immunodeficiency virus-infected patients: a prospective, randomized pilot study.  J Infect Dis. 1993;  168 1332-1333
    Google Scholar
  • 26 Hoffmann C. Opportunisctische Infektionen. Hoffman C, Rockstroh J, Kamps BS HIV.NET Wuppertal-Weyenburg; Steinhäuser Verlag 2005 6: 243-307
    Google Scholar
  • 27 Hernandez-Sampelayo T. Multicenter Study Group . Fluconazole versus ketaconazole in the treatment of oropharyngeal candidiasis in HIV-infected children.  Eur J Clin Microbiol Infect Dis. 1994;  13 340-344
    Google Scholar
  • 28 Laine L, Dretler R H, Conteas C N. et al . Fluconazole compared with ketoconazole for the treatment of candida esophagitis in AIDS: a randomized trial.  Ann Intern Med. 1992;  117 655-660
    Google Scholar
  • 29 Barbaro G, Barbarini G, Caladeron W. et al . Fluconazole versus itraconazole for Candida esophagitis in acquired immunodeficiency syndrome.  Gastroenterology. 1996;  111 1169-1177
    Google Scholar
  • 30 Gallant J E, Moore R D, Chaisson R E. Prophylaxis for opportunistic infections in patients with HIV infection.  Ann Intern Med. 1994;  120 932-944
    Google Scholar
  • 31 Marriott D JE. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients: a doubleblind placebo-controlled study.  Med J Aust. 1993;  158 312-316
    Google Scholar
  • 32 Leen C LS, Dunbar E M, Ellis M E. et al . Once-weekly f1uconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.  J Infect. 1990;  21 55-60
    Google Scholar
  • 33 Martin D F, Sierra-Madero J, Walmsley S. et al . A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.  N Engl J Med 2002. 2002;  346 1119-1126
    Google Scholar
  • 34 Dieterich D T, Chachoua A, Lafleur F. et al . Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS.  Rev Infect Dis. 1988;  10 532-537
    Google Scholar
  • 35 Wilcox C M, Straub R F, Schwartz D A. Cytomegalovirus esophagitis in AIDS: a prospective study of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.  Am J Med. 1995;  98 169-176
    Google Scholar
  • 36 Blanshard C. Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet.  J Acquir Immune Defic Syndr. 1992;  1 25-28
    Google Scholar
  • 37 Dieterich D T, Kotler D P, Busch D F. et al . Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebocontrolled multicenter study.  J Infect Dis. 1993;  167 278-282
    Google Scholar
  • 38 Parente F, Bianchi Porro G. Treatment of cytomegalovirus esophagitis in patients with acquired immunodeficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir; the Italian Cytomegalovirus Study Group.  Am J Gastroenterol. 1998;  93 317-322
    Google Scholar
  • 39 Blanshard C, Benhamou Y, Dohin E. et al . Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison.  J Infect Dis. 1995;  172 622-628
    Google Scholar
  • 40 Mönkemüller K E, Wilcox C M. Esophageal ulcer caused by cytomegalovirus: resolution during combination antiretroviral therapy for acquired immunodeficiency syndrome.  South Med J. 2000;  93 818-820
    Google Scholar
  • 41 Murdoch D M, Venter W D, Van Rie A. et al . Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.  AIDS Res Ther. 2007;  4 9
    Google Scholar
  • 42 Laskin O L. Clinical pharmacokinetics of acyclovir.  Clin Pharmacokinet. 1983;  8 187-201
    Google Scholar
  • 43 Safrin S. Treatment of acyclovir-resistant herpes simplex virus in patients with AIDS.  J Acquir Immune Defic Syndr. 1992;  1 29-32
    Google Scholar
  • 44 Hardy W. Foscarnet treatment of acyclovir-resistant herpes simplex virus in patients with acquired immunodeficiency syndrome: preliminary results a controlled, randomized, regimen-comparative trial.  Am J Med. 1992;  92 30-35
    Google Scholar
  • 45 Wilcox C M, Schwartz D A. Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer.  Am J Gastroenterol. 1994;  89 2163-2167
    Google Scholar
  • 46 Nelson M R, Erskine D, Hawkins D A. et al . Treatment with corticosteroids: a risk factor for the development of clinical cytomegalovirus disease in AIDS.  AIDS. 1993;  7 375-378
    Google Scholar
  • 47 Paterson D L, Georghiou P R, Allworth A M. et al . Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.  Clin Infect Dis. 1995;  20 250-254
    Google Scholar
  • 48 Alexander L N, Wilcox C M. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers.  AIDS Res Hum Retroviruses. 1997;  13 301-304
    Google Scholar
  • 49 Mönkemüller K, Wilcox C M. Diseases of the esophagus, stomach and bowel. Dolin R, Masur H, Saag MS AIDS Therapy 2nd Ed New York; Churchill Livingstone 2003 64: 885-901
    Google Scholar
  • 50 Fichtenbaum C J. Candidiasis. Dolin R, Masur H, Saag MS AIDS Therapy, 2nd Ed New York; Churchill Livingstone 2003 39: 85-901
    Google Scholar

Dr. Klaus Mönkemüller

Gastroenterologie, Hepatologie und Infektiologie, Uniklinikum Magdeburg

Leipzigerstr. 44

39120 Magdeburg

Phone: ++ 49/3 91/6 71 31 00

Fax: ++ 49/3 91/6 71 31 05

Email: klaus.moenkemueller@medizin.uni-magdeburg.de

      >